Fronteo Inc – American Depositary Shares (NASDAQ:FTEO) Stock Is Shorted Less

The stock of Fronteo Inc – American Depositary Shares (NASDAQ:FTEO) registered a decrease of 57.14% in short interest. FTEO’s total short interest was 300 shares in December as published by FINRA. Its down 57.14% from 700 shares, reported previously. With 100 shares average volume, it will take short sellers 3 days to cover their FTEO’s short positions.

It closed at $15.91 lastly. It is down 38.63% since December 8, 2017 and is uptrending. It has outperformed by 23.01% the S&P500.

FRONTEO, Inc. provides Asian-language eDiscovery solutions and services primarily in the United States, Europe, and Asia. The company has market cap of $300.94 million. The firm has eDiscovery and forensic experience with information documented in Japanese, Korean, and Chinese, as well as English. It has a 82.86 P/E ratio. It assists clients involved in cross-border litigation, administrative proceedings, and internal investigations, including those related to antitrust investigations, intellectual property litigation, the Foreign Corrupt Practices Act, and product liability investigations.

More notable recent FRONTEO, Inc. (NASDAQ:FTEO) news were published by: which released: “FRONTEO USA Appoints eDiscovery Veteran as Senior Vice President of Sales & Marketing – GlobeNewswire” on July 11, 2017, also with their article: “UBIC announces corporate name change to FRONTEO – GlobeNewswire” published on May 26, 2016, published: “FRONTEO Acquires Essential Discovery, Inc. Nasdaq:FTEO – GlobeNewswire” on November 07, 2016. More interesting news about FRONTEO, Inc. (NASDAQ:FTEO) were released by: and their article: “FRONTEO USA Appoints Industry Veteran as Chief Financial Officer – GlobeNewswire” published on May 01, 2017 as well as‘s news article titled: “Japanese Foundation for Cancer Research and FRONTEO Healthcare, Inc. Jointly Research Cancer Precision Medicine – GlobeNewswire” with publication date: April 28, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.